Quris, an AI-powered prediction platform for clinical trials, is prepping to raise as much as $100 million in Series A capital, CEO Isaac Bentwich tells Axios exclusively.
Why it matters: The ambitious round size reflects industry appetite for solutions that make clinical trials simpler and more efficient.
